Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

Presentation TCT 2017

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Cosmo Godino, MD

November 01, 2017

Presentation TCT 2017

TCT 20: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions not Revascularized by Percutaneous Coronary Intervention According to Left Ventricle Systolic Function

Presenter: James C. Spratt, R. Michael Wyman, Cosmo Godino, MD

October 31, 2017

Presentation JIM 2016

Beneficial effects of heart rate reduction on residual ischemia

Presenter: Cosmo Godino

February 11, 2016

Presentation TCT 2012

Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.

Presenter: Gill L. Buchanan, Alfonso Ielasi, Alaide Chieffo, Matteo Montorfano, Cosmo Godino, Azeem Latib, Mauro Carlino, Antonio Colombo

January 03, 2012

Presentation TCT 2012

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Presenter: Kensuke Takagi, Alfonso Ielasi, Joanne Shannon, Azeem Latib, Cosmo Godino, Giedrius Davidavicius, Marco Mussardo, Santo Ferrarello, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Sunao Nakamura, Antonio Colombo

January 03, 2012

Presentation TCT 2012

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

January 03, 2012

Advertisement

Study Affirms Thrombotic Risk in COVID-19

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

TCT 20: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions not Revascularized by Percutaneous Coronary Intervention According to Left Ventricle Systolic Function

Beneficial effects of heart rate reduction on residual ischemia

Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.

Impact of Initial Procedure and Revascularization Strategy on the Treatment of Drug-Eluting Stent Restenosis Following Unprotected Distal Left Main PCI: the Milan and...

Five-Year Outcomes of Sirolimus-Eluting Stent in Patients with Unprotected Left Main Coronary Arteries: the Milan and New-Tokyo Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content